Nonpurulent lower extremity cellulitis (NLEC) is a common clinical diagnosis, with b-hemolytic streptococci and Staphylococcus aureus considered to be the most frequent causes. In 1999, the US Public Health Service alerted clinicians to the presence of community-acquired methicillin-resistant S aureus (CA-MRSA) infections in 4 children in the upper Midwest. Since then, it has become a well-recognized cause of skin and soft-tissue infections, in particular, skin abscess. A previous population-based study of NLEC in Olmsted County, Minnesota, reported an unadjusted incidence rate of 199 per 100,000 person-years in 1999, but it is unknown whether CA-MRSA subsequently has affected NLEC incidence. We, therefore, sought to determine the population-based incidence of NLEC since the emergence of CA-MRSA. Age-and sex-adjusted incidence (per 100,000 persons) of NLEC was 176.6 (95% CI, 151.5-201.7). Incidence differed significantly between sexes with age-adjusted sex-specific rates of 133.3 (95% CI, 104.1-162.5) and 225.8 (95% CI, 183.5-268.0) in females and males, respectively. Seasonal incidence differed, with rates of 224.6 (95% CI, 180.9-268.4) in warmer months (May-September) compared with 142.3 (95% CI, 112.8-171.9) in colder months (January-April and October-December). Despite emergence and nationwide spread of CA-MRSA since 1999 in the United States, the incidence of NLEC in Olmsted County was lower in 2013 than in 1999, particularly in females. This suggests that CA-MRSA is not a significant cause of NLEC and that NLEC cases are seasonally distributed. These findings may be important in formulation of empirical therapy for NLEC and in patient education because many patients with NLEC are prone to recurrent bouts of this infection. 
N onpurulent lower extremity cellulitis (NLEC) is one of the most common skin/soft-tissue infections (SSTIs) encountered by clinicians.
1,2 Despite its frequency in clinical practice, few studies describe the incidence of NLEC, which has ranged from 19 to 2740 per 100,000 personyears. [3] [4] [5] [6] Most of these studies did not include individual medical record review, and by using only International Classification of Diseases, Ninth Revision (ICD-9) codes, their incidence figures included patients with purulent SSTIs because cellulitis and skin abscess share a common ICD-9 code (681.x). To our knowledge, only 1 study has described the incidence of NLEC in a population-based cohort in the United States (199 per 100,000 person-years in 1999) and included individuals from Olmsted County, Minnesota. 7 Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) has been described as early as the 1980s as a cause of bacterial endocarditis in intravenous drug abusers. 8 The first cases of CA-MRSA causing purulent SSTIs were seen in the 1990s in the United States. 9, 10 In response to an increase in infections due to CA-MRSA, the US Public Health Service began monitoring the prevalence of CA-MRSA infections in this country. Changes in the prevalence of CA-MRSA in Minnesota have been prospectively monitored by 12 sentinel hospital-based laboratories throughout the state. 11 In 2000, the prevalence of CA-MRSA infections among all MRSA infections in Minnesota was 11% and had significantly increased to 33% by the end of 2005. 12 Most CA-MRSA infections were SSTIs, increasing from 75% to 87% between 2000 and 2005. 12 Whether CA-MRSA has caused a similar increase in NLEC cases, however, remained undefined. Establishing or refuting a causal link between CA-MRSA and NLEC is difficult because microbiologic data are not obtained in the bulk of NLEC cases. Due to the overall increase in SSTI prevalence since the emergence of CA-MRSA, there may be an understandable inference that CA-MRSA may play a role in NLEC. Such inferences may lead to empirical antimicrobial prescribing practices that include unnecessary coverage for CA-MRSA. Therefore, if one could demonstrate that despite the increase in incidence of SSTIs caused by CA-MRSA, the incidence of NLEC had remained unchanged, then this could justify the selection of empirical antibiotic drug therapy for NLEC that does not include coverage for CA-MRSA. In this regard, no studies have evaluated the influence of CA-MRSA on the incidence of NLEC. In the present study, we, therefore, define the incidence of NLEC after the emergence of CA-MRSA in the United States by using the same population-based cohort evaluated by our group in 1999. 7 
METHODS
This retrospective, population-based study was conducted in Olmsted County in adult residents with NLEC from January 1 through December 31, 2013. Medical records were accessible through the Rochester Epidemiology Project (REP), a medical records linkage system for all county-based medical facilities. 13 The initial set of potential cases was identified using the same ICD-9 codes for cellulitis and abscess as were used in the 1999 study 7 (Supplemental Table 1 , available online at http://www.mayoclinicproceedings. org). Current Procedural Terminology codes were applied to exclude patients with purulent SSTIs requiring procedural drainage (Supplemental Table 2 , available online at http://www.mayoclinicproceedings.org).
Medical records were reviewed and cases were initially included or excluded by trained nurse abstractors. One of us (J.R.M.) rereviewed cases to confirm that they met the case definition or were appropriately excluded. Another one of us (L.M.B.) independently randomly reviewed 5% of all medical records (n¼93); agreement was 96% on medical record classification. Without laboratory gold standards for NLEC diagnosis, previous studies have accepted the evaluating clinician's diagnosis. Our case definition is consistent with that used in recent studies 7, 14, 15 : a clinician's clinical diagnosis with documentation of acute onset of warmth, erythema, and edema on the lower extremities. Excluded patients had purulent or necrotizing SSTIs, osteomyelitis, secondary skin infections, burn wounds, infected prosthetic material, or infected human or animal bite wounds. Warmer months (May-September) and colder months (January-April and OctoberDecember) were predetermined according to seasonal periods identified in the 1999 study. 7 
Statistical Analyses
To examine the incidence of NLEC, count data for cases and total person-time were generated for subsets of the local population defined by sex and age (in single years from age 18-100 years). Numbers of persons in Olmsted County were ascertained via linkage with data sources from the REP, which provide a reliable means for enumerating population estimates. 16 Unadjusted incidence rates were derived using counts of cases in the numerator and the corresponding counts of the county population in the denominator. Age-and sex-adjusted rates were computed based on direct standardization against the 2010 US white population, 17 with 95% CIs estimated using the Poisson distribution.
All incidence rates are presented per 100,000 person-years; calculations of monthly and seasonal incidence rates required correcting the population counts to compensate for an observation period shorter than 1 year (eg, for monthly incidence, counts were multiplied by a constant of 1/12). Smoothing techniques based on the nonparametric loess method were used to illustrate the relation of age, sex, and calendar time with incidence rate, and multivariable Poisson regression was used to test for independent differences in rates between the levels of each risk factor. The model was formulated with number of cases as the dependent variable and number of total person-years on log scale as an offset variable; independent covariates included age as a continuous variable, and sex and season (warm/cold) as binary variables. Analyses were performed using SAS statistical software (Version 9.4; SAS Institute Inc). Further details of the statistical rationale associated with incidence comparisons are outlined in the Supplemental Box (available online at http:// www.mayoclinicproceedings.org).
Human Subject Protection
The Mayo Clinic and Olmsted County Medical Center institutional review boards approved this study. All patients participating in the REP have previously consented to the research use of their medical records.
RESULTS

Cohort Characteristics
A total of 1867 records were initially identified from the REP as potential NLEC episodes based on diagnostic codes. Of these, 195 individuals (10.4%) met the definition for incident cases of NLEC. Most patients were of white race (96.4%), male (57.9%), and diagnosed in the outpatient setting (67.2%). All the patients presented with erythema and received antibiotic drugs. Twenty-eight patients (14.4%) required hospitalization for a median of 3.5 days (Table 1) .
Incidence During 2013, the unadjusted incidence rate of NLEC was 168.6 per 100,000 persons. When standardized to the 2010 US white population, the overall age-and sex-adjusted incidence (per 100,000 persons) of NLEC was 176.6 (95% CI, 151.5-201.7), with age-adjusted rates of 133.3 (95% CI, 104.1-162.5) in females and 225.8 (95% CI, 183.5-268.0) in males ( Table 2) . Multivariable Poisson regression analysis revealed that the incidence of NLEC was significantly higher in males than in females (P<.001) and that the incidence rates increased with older age (P<.001) (Figure) . Table 2 and the Supplemental Figure (available online at http://www.mayoclinicproceedings. org) show the seasonal effect on the incidence of NLEC, with age-and sex-adjusted rates (per 100,000 persons) of 224.6 (95% CI, 180.9-268.4) in the warmer months (MaySeptember) compared with 142.3 (95% CI, 112.8-171.9) in the colder months (JanuaryApril and October-December). In the multivariable model adjusted for age and sex, this seasonal difference was significant (P¼.001) This designation was used when the medical record indicated that nonpurulent lower extremity cellulitis was present on the lower extremity without specifying the anatomical location. and corresponded to a 1.6-fold (95% CI, 1.2-to 2.1-fold) higher incidence in warmer months. From sex-stratified models, the seasonal difference was significant in females (2.2-fold higher in warmer months; P<.001) and nonsignificant in males (1.3-fold higher in warmer months; P¼.19).
Seasonal Variation
DISCUSSION
A comparison of the incidence of NLEC before and after the emergence of CA-MRSA is of keen interest because it is widely recognized as a cause of SSTI, predominantly skin abscess. This investigation was performed in the same setting with the same case definition as a previous study of the incidence of NLEC in Olmsted County in 1999, which found an unadjusted incidence of 199.2 per 100,000 persons. 7 However, when contrasting the incidence rates between the present and the previous study, it is important to account for potential age and sex differences in the local population between 1999 and 2013. To improve the comparability between studies, the 1999 incidence was reevaluated by standardizing rates to the age and sex distributions of the base population (2010 US whites) used in the present study (described in detail in the Supplemental Materials, available online at http://www.mayoclinicproceedings.org).
In addition, aggregate data from 1999 and 2013 were analyzed with statistical modeling to compensate for population differences, allowing a direct comparison of rates between years to investigate changes in incidence of NLEC since CA-MRSA emergence. The overall ageand sex-adjusted incidence of NLEC for 1999 was 216.0 per 100,000, exceeding the corresponding rate of 176.6 per 100,000 that we report for 2013 (P¼.045). This difference suggests that the incidence of NLEC in Olmsted County has not increased, and perhaps has even decreased, despite the increase in prevalence of CA-MRSA over the years. A similar decrease in the incidence of SSTIs (although not specific to NLEC) was described recently at a Chicago medical center. 18 Similar to the 1999 study, the present data showed a significant increase in the incidence of NLEC with increasing age. 7 Unlike the 1999 study, however, the NLEC incidence differed by sex. According to age-adjusted rates, the incidence of NLEC in males was similar between 1999 and 2013 (227.1 and 225.8 per 100,000, respectively; P¼.82), whereas the incidence in females was significantly lower in 2013 (181.2 and 132.6 per 100,000, respectively; P¼.009). The present finding of a lower rate in females compared with males is consistent with the comparisons of sex-specific incidence between 1999 and 2013, which suggest that the current rate in females is lower than previously reported.
Although we did not have prevalence rates for CA-MRSA specific to Olmsted County, the rates described for Minnesota can be considered representative, as the sentinel hospitals were chosen to represent the demographic characteristics of patients served across the state. 12, 19 A decrease in the incidence of NLEC despite the prevalence of CA-MRSA is noteworthy because providers often use antimicrobial agents that include coverage for CA-MRSA for NLEC. 20 In the present cohort, 63% of patients received cephalexin; however, 16% and 11% of patients received trimethoprim/sulfamethoxazole or vancomycin, respectively (data not shown), despite the absence of a Unadjusted incidence is presented as number of NLEC cases along with the crude incidence rate for all age-sex groups, and adjusted incidence rates are computed by season or overall and are accompanied by 95% CIs and are age and sex standardized (or age standardized for sex-specific incidence) to the US white population in 2010. Multivariable Poisson regression analysis revealed independent effects of age, sex, and season on rates of incidence, with older age (P<.001), male sex (P<.001), and warm season (P¼.001) each associated with a higher incidence of NLEC.
b
The prespecified interval of May through September was used to represent warm seasonal months. c The remaining months of January through April and October through December were considered to be cold seasonal months.
purulence. Current Infectious Diseases Society of America guidelines acknowledge that "MRSA is an unusual cause of typical cellulitis"; in fact, they suggest that it is inappropriate to designate the term cellulitis to any SSTI that includes a collection of purulence. 2 Nevertheless, current guidelines suggest clindamycin (which covers MRSA) as an option for the treatment of mild/moderate nonpurulent SSTIs. 2 Clindamycin as monotherapy for NLEC may be problematic given the increased risk of diarrhea, 21 including fatal and nonfatal adverse events relating to Clostridium difficile infections. 22 The present data indicate that an increased incidence of SSTIs mediated by a rising prevalence of CA-MRSA has had little effect on the incidence of NLEC, suggesting that empirical coverage of CA-MRSA may be unnecessary. In a randomized controlled trial comparing the effectiveness of trimethoprim/sulfamethoxazole vs cephalexin for the treatment of uncomplicated (nonpurulent) cellulitis, combination therapy with both agents did not affect the outcomes of cellulitis compared with cephalexin monotherapy. 23 Similarly, in another randomized controlled trial comparing outcomes, adding clindamycin to flucloxacillin did not improve outcomes of cellulitis compared with flucloxacillin monotherapy. 21 An analysis of outcomes of empirical therapy in the present study would have strengthened the conclusions if this showed that patients treated empirically without CA-MRSA coverage did no worse than those treated with CA-MRSA coverage. However, the retrospective nature of this study made it difficult to obtain these data because many patients did not return for evaluation after initial treatment; although one may assume that their condition improved, this assumption cannot be verified. The present data ultimately can be used, with data from other studies, to impact the designation of empirical antibiotic drug regimens promulgated by future guidelines to enhance clinical outcomes and promote antimicrobial stewardship in the initial management of NLEC.
Finally, the impact of seasonality on SSTI occurrence has been described with more cases in the summer or wetter months. 7, 18 Review of the available literature identified only 4 studies specifically describing seasonal variations in NLEC. 7, [24] [25] [26] Moreover, the only US study to note seasonal variation in NLEC was the one conducted in our population in 1999. 7 Recognition of seasonality in the epidemiology of NLEC is important as we consider educational aspects for both clinicians and patients. This could include enhanced recognition by clinicians of the diagnosis of NLEC in the differential diagnosis of this syndrome among a variety of other diseases that can mimic cellulitis. 27 In addition, patient education for those at high risk for an initial bout of cellulitis or a recurrent bout could include aggressive treatment of tinea pedis for those with this infection and the use of protective clothing during warmer months.
Limitations
The retrospective design relies on accurate medical records with proper documentation and diagnostic coding for capture of true cases Age (y)
FIGURE.
Relationship of age and sex with incidence of nonpurulent lower extremity cellulitis (NLEC) in Olmsted County, Minnesota (2013). Incidence data specifying counts of NLEC cases (numerator) and counts of total at-risk adults (denominator) were organized into strata specific to sex and each single year of age (range, 18-100 years). Using this granular form of data, smoothing techniques (loess algorithm) were used to estimate incidence in relation to age and sex. Symbols represent sex-specific incidence rates estimated according to age groups (those shown in Table 2 ) to provide a crude verification of the smoothed trends. In a multivariable Poisson regression model, rates of incidence were higher in males and increased with age for both sexes (P<.001 for age and sex effects).
and assumes that patients with NLEC will seek health care. This could introduce bias toward more severe cases; however, this is unlikely because most patients did not require hospitalization for NLEC. In addition, medical records were individually examined to verify strict adherence to a standardized case definition.
CONCLUSION
The incidence of NLEC in Olmsted County was lower in 2013 than that reported in 1999, before the emergence of CA-MRSA. This suggests that, unlike skin abscess, CA-MRSA does not play a major role as a cause of NLEC. This, coupled with the results of a clinical trial that examined the role of CA-MRSA coverage in nonpurulent cellulitis, suggests that empirical coverage of CA-MRSA in cases of NLEC is unnecessary. In addition, cases of NLEC are seasonally distributed, with more cases occurring in spring/summer. Revised clinical recommendations for empirical treatment and risk factor modification to prevent NLEC should, therefore, be considered.
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